| Product Code: ETC7352336 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Bhawna Singh | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Greece Lumasiran Market Overview |
3.1 Greece Country Macro Economic Indicators |
3.2 Greece Lumasiran Market Revenues & Volume, 2021 & 2031F |
3.3 Greece Lumasiran Market - Industry Life Cycle |
3.4 Greece Lumasiran Market - Porter's Five Forces |
3.5 Greece Lumasiran Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.6 Greece Lumasiran Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Greece Lumasiran Market Revenues & Volume Share, By Dosage form, 2021 & 2031F |
3.8 Greece Lumasiran Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.9 Greece Lumasiran Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.10 Greece Lumasiran Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Greece Lumasiran Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Growing awareness and adoption of gene-silencing therapies in Greece |
4.2.2 Increasing prevalence of rare diseases, such as primary hyperoxaluria type 1 (PH1), which lumasiran targets |
4.2.3 Favorable government regulations and policies supporting the development and accessibility of rare disease treatments |
4.3 Market Restraints |
4.3.1 High cost associated with lumasiran treatment may limit patient access and adoption |
4.3.2 Limited healthcare infrastructure and resources in certain regions of Greece may impact the distribution and availability of lumasiran |
5 Greece Lumasiran Market Trends |
6 Greece Lumasiran Market, By Types |
6.1 Greece Lumasiran Market, By Drug Class |
6.1.1 Overview and Analysis |
6.1.2 Greece Lumasiran Market Revenues & Volume, By Drug Class, 2021- 2031F |
6.1.3 Greece Lumasiran Market Revenues & Volume, By Miscellaneous Metabolic Agents, 2021- 2031F |
6.1.4 Greece Lumasiran Market Revenues & Volume, By others, 2021- 2031F |
6.2 Greece Lumasiran Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Greece Lumasiran Market Revenues & Volume, By Primary Hyperoxaluria, 2021- 2031F |
6.2.3 Greece Lumasiran Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Greece Lumasiran Market, By Dosage form |
6.3.1 Overview and Analysis |
6.3.2 Greece Lumasiran Market Revenues & Volume, By Injection, 2021- 2031F |
6.3.3 Greece Lumasiran Market Revenues & Volume, By Solution, 2021- 2031F |
6.4 Greece Lumasiran Market, By Route of Administration |
6.4.1 Overview and Analysis |
6.4.2 Greece Lumasiran Market Revenues & Volume, By Subcutaneous, 2021- 2031F |
6.4.3 Greece Lumasiran Market Revenues & Volume, By Demographic, 2021- 2031F |
6.4.4 Greece Lumasiran Market Revenues & Volume, By Adult, 2021- 2031F |
6.4.5 Greece Lumasiran Market Revenues & Volume, By Pediatric, 2021- 2031F |
6.5 Greece Lumasiran Market, By End-Users |
6.5.1 Overview and Analysis |
6.5.2 Greece Lumasiran Market Revenues & Volume, By Clinics, 2021- 2031F |
6.5.3 Greece Lumasiran Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.5.4 Greece Lumasiran Market Revenues & Volume, By Diagnostic center, 2021- 2031F |
6.6 Greece Lumasiran Market, By Distribution Channel |
6.6.1 Overview and Analysis |
6.6.2 Greece Lumasiran Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.6.3 Greece Lumasiran Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.6.4 Greece Lumasiran Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
7 Greece Lumasiran Market Import-Export Trade Statistics |
7.1 Greece Lumasiran Market Export to Major Countries |
7.2 Greece Lumasiran Market Imports from Major Countries |
8 Greece Lumasiran Market Key Performance Indicators |
8.1 Patient enrollment in clinical trials for gene-silencing therapies in Greece |
8.2 Number of healthcare providers trained in administering lumasiran treatment |
8.3 Patient adherence and persistence rates with lumasiran therapy |
8.4 Rate of reimbursement approvals for lumasiran treatment by insurance providers |
8.5 Number of publications and scientific studies on the efficacy and safety of lumasiran in treating PH1 |
9 Greece Lumasiran Market - Opportunity Assessment |
9.1 Greece Lumasiran Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.2 Greece Lumasiran Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Greece Lumasiran Market Opportunity Assessment, By Dosage form, 2021 & 2031F |
9.4 Greece Lumasiran Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.5 Greece Lumasiran Market Opportunity Assessment, By End-Users, 2021 & 2031F |
9.6 Greece Lumasiran Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Greece Lumasiran Market - Competitive Landscape |
10.1 Greece Lumasiran Market Revenue Share, By Companies, 2024 |
10.2 Greece Lumasiran Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here